Concepedia

Yenealem Temesgen‐Oyelakin

YT

Statistics

Publications

7

Citations

496

H-Index

7

Active since

2018

Affiliations

National Institute of Arthritis and Musculoskeletal and Skin Diseases(Current)

National Institutes of Health

National Heart Lung and Blood Institute

National Institutes of Health Clinical Center

Carolina Arthritis Associates

Yenealem Temesgen‐Oyelakin is an author at National Institute of Arthritis and Musculoskeletal and Skin Diseases specializing in systemic lupus erythematosus, clinical trials, and systemic lupus erythematosus treatment.

Top concepts

Publications per year

2018–2024

7

Publications

7

Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus

Sarfaraz Hasni, Sarthak Gupta, Michael A. Davis et al. · Nature Communications · 2021 · 182 citations · Full text

Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus

Philip M. Carlucci, Monica Purmalek, Amit K. Dey et al. · JCI Insight · 2018 · 179 citations · Full text

Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti‐IgE Monoclonal Antibody in Systemic Lupus Erythematosus

Sarfaraz Hasni, Sarthak Gupta, Michael A. Davis et al. · Arthritis & Rheumatology · 2018 · 62 citations · Full text

Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE

Monica Purmalek, Philip M. Carlucci, Amit K. Dey et al. · Lupus Science & Medicine · 2019 · 25 citations · Full text

Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus

Sarfaraz Hasni, Yenealem Temesgen‐Oyelakin, Michael A. Davis et al. · Annals of the Rheumatic Diseases · 2022 · 24 citations · Full text

Rows per page

1–5 of 7